Décret n° 2000-2339 du 10 octobre 2000, fixant la liste des déchets dangereux (JORT n° 86 du 27 octobre 2000) Sur proposition de la ministre de l'environnement et de l’aménagement du territoire, Vu la loi n° 92-11 du 3 février 1992, portant ratification de la convention de "Bamako" sur l'interdiction d'importer en Afrique des déchets dangereux et sur le contrôle des mo
Microsoft word - o-0016 blue lotus moisturizing mask.doc
This soft, revitalizing facial mask deep cleanses and removes dead cells. It leaves the skin fresh
and moisturized after rinse off without feeling dry or “pulled”. A combination of both light and
heavy Schercemol™* Esters provide a silky application and long-lasting emolliency.
Promulgen™* D Emulsifier, a highly cost effective non-ionic emulsifier, acts as an emulsion
stabilizer and viscosity builder. Hydramol™* Esters are excellent humectants and conditioners.
Phenoxyethanol, Methyl-, Ethyl-, Butyl-, Propyl-, (and) Isobutylparaben, Phenoxyethanol, Methyl-, Ethyl-, Butyl-, Propyl-, (and) Isobutylparaben, 1. Add water to mixing vessel. Dissolve EDTA into water with good agitation. 2. Add remaining ingredients in PART A in order shown. 3. Sprinkle ingredients in PART B to PART A one at a time and mix with good agitation. 5. In a separate vessel, combine ingredients in PART C and heat to 80°C. 6. Add PART C to PART A/B and continue mixing while cooling to 40°C. 7. Add ingredients in PART D in the order shown. Mix while cooling to 35°C. Product Properties:
Specific Gravity (g/ml) 1.00 – 1.05 Total Solids (%) Passed 2 months @ 40°C, 1 month @ 50°C, 3 cycles freeze/thaw ** Brookfield RVT @ 20 rpm, #6 spindle, measured after 24 hours Supplier References: Protameen (2) Noveon, Inc. (3, 9, 10, 11, 16) Clariant Corporation (4, 15) Ashland (5) Mineral and Pigment Solutions, Inc. (6, 7, 8) Lipo (12) Cognis (13) Chemyunion (14) Premier Specialties, Inc. (17) Quantum Colours(18, 19) The information contained herein is believed to be reliable, but no representations, guarantees or warranties of any kind are made as to its accuracy, suitability for particular applications or the results to be obtained. The information often is based on laboratory work with smal -scale equipment and does not necessarily indicate end product performance or reproducibility. Formulations presented may not have been tested for stability and should be used only as a suggested starting point. Because of the variations in methods, conditions and equipment used commercial y in processing these materials, no warranties or guarantees are made as to the suitability of the products for the applications disclosed. Full-scale testing and end product performance are the responsibility of the user. Noveon, Inc. shal not be liable for and the customer assumes al risk and liability for any use or handling of any material beyond Noveon’s direct control. The SELLER MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. Nothing contained herein is to be considered as permission, recommendation, nor as an inducement to practice any patented invention without permission of the patent owner. Noveon, Inc. is a whol y owned subsidiary of The Lubrizol Corporation *Trademark owned by The Lubrizol Corporation Copyright 2005 Noveon, Inc.
An Update on Local Anesthetics in Dentistry • Daniel A. Haas, BSc, DDS, BScD, PhD, FRCD(C) • Local anesthetics are the most commonly used drugs in dentistry. This article provides a brief update on thepharmacology, adverse effects and clinical applications of these drugs, as well as the role of vasoconstrictors. MeSH Key Words: anesthesia, dental; anesthetics, local/adverse effects;